[1] Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients[J]. N Engl J Med, 2001,345(19):1359-1367.[2] 崔乃杰.脓毒症多器官功能障碍综合征治疗进展[J].中华急诊医学杂志,2003,12(1):67-68.[3] 韩璐,马涛,故文全,等.脓毒症的点胶损伤[J].中国煤炭工业医学杂志,2012,15(6):890-892[4] Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress[J]. Circulation, 2002,106(16):2067-2072.[5] 王涛,李春盛.危重病患者血脑变化及其对预后的影响[J].中国医科大学学报,2011,40(6):843-847.[6] The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients[J]. N Engl J Med, 2009,360(13):1283-1297.[7] Griesdale D E, de Souza R J, van Dam R M, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data[J]. CMAJ, 2009,180(8):821-827.[8] Krinsley J S. Glycemic control, diabetic status and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital[J]. Semin Thorac Cardiovasc Surg, 2006,18(4):317-325.[9] Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes[J]. Crit Care Med, 2008,36(3):2249-2255.[10] 胡耀敏,刘伟,陈雅文,等.内科重疗监护病房住院患者926例高血糖临床资料分析-上海仁济医院2002至2009年资料回顾[J].中华内分泌代谢杂,2010,26(5):448-451.[11] Dungan K M, Braithwaite S S, Preiser J C. Stress hyperglycaemia[J]. Lancet, 2009,373(9677):1798-1807.[12] Moghissi E S, Korytkowski M T, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus on inpatient glycemic contro1[J]. Diabetes Care, 2009,32(6):1119-1131.[13] 杨文英.重视颅防,规范管理-2007年版《中国2型糖尿病防治指南》[J].中华内分泌代谢杂志,2008,24(2):121-122.[14] International Expert Committee. International Expert Committee report on the role of the AIC assay in the diagnosis of diabetes[J]. Diabetes Care, 2009,32(suppl 2):1327-1334. |